Literature DB >> 12595036

PEGylation of the antimicrobial peptide nisin A: problems and perspectives.

Andrea Guiotto1, Michela Pozzobon, Mirta Canevari, Riccardo Manganelli, Marino Scarin, Francesco M Veronese.   

Abstract

Nisin is a natural antimicrobial peptide produced by Lactococcus lactis and widely employed as food preservative. Its low solubility in neutral aqueous solutions, its instability at physiological pH and its rapid breakdown by proteolytic enzymes has limited its use for processed foods (processed cheese, milk and derivatives, canned vegetables). The conjugation to poly(ethylene glycol) (PEG) could improve its solubility and protect it towards enzymes present in non optimally processed food. We report the synthesis of a PEG-nisin conjugate, and the microbiology assays against some bacterial cell lines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595036     DOI: 10.1016/S0014-827X(02)01301-0

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  10 in total

1.  Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery.

Authors:  Christopher J Morris; Konrad Beck; Marc A Fox; David Ulaeto; Graeme C Clark; Mark Gumbleton
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

2.  C-terminal mini-PEGylation of a marine peptide N6 had potent antibacterial and anti-inflammatory properties against Escherichia coli and Salmonella strains in vitro and in vivo.

Authors:  Ting Li; Na Yang; Da Teng; Ruoyu Mao; Ya Hao; Xiumin Wang; Jianhua Wang
Journal:  BMC Microbiol       Date:  2022-05-12       Impact factor: 4.465

3.  Immobilization reduces the activity of surface-bound cationic antimicrobial peptides with no influence upon the activity spectrum.

Authors:  Mojtaba Bagheri; Michael Beyermann; Margitta Dathe
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

4.  In vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae.

Authors:  Ana Paula Galvão da Silva; Donovan Unks; Shu-chen Lyu; Jeffrey Ma; Renata Zbozien-Pacamaj; Xi Chen; Alan M Krensky; Carol Clayberger
Journal:  J Antimicrob Chemother       Date:  2008-02-29       Impact factor: 5.790

5.  Evaluation of in vitro cytotoxic activity of mono-PEGylated StAP3 (Solanum tuberosum aspartic protease 3) forms.

Authors:  Fernando Muñoz; Pablo C Caracciolo; Gustavo Daleo; Gustavo A Abraham; M Gabriela Guevara
Journal:  Biotechnol Rep (Amst)       Date:  2014-05-27

Review 6.  Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo.

Authors:  Prashant Kumar; Jayachandran N Kizhakkedathu; Suzana K Straus
Journal:  Biomolecules       Date:  2018-01-19

7.  Inactivation of Bacteria Using Bioactive Nanoparticles and Alternating Magnetic Fields.

Authors:  Vitalij Novickij; Ramunė Stanevičienė; Rūta Gruškienė; Kazimieras Badokas; Juliana Lukša; Jolanta Sereikaitė; Kęstutis Mažeika; Nikolaj Višniakov; Jurij Novickij; Elena Servienė
Journal:  Nanomaterials (Basel)       Date:  2021-01-29       Impact factor: 5.076

Review 8.  Molecular engineering of antimicrobial peptide (AMP)-polymer conjugates.

Authors:  Zixian Cui; Qinmo Luo; Mark S Bannon; Vincent P Gray; Taylor G Bloom; Madeline F Clore; Molly A Hughes; Matthew A Crawford; Rachel A Letteri
Journal:  Biomater Sci       Date:  2021-06-07       Impact factor: 7.590

9.  Recombinant expression, purification and PEGylation of Paneth cell peptide (cryptdin-2) with value added attributes against Staphylococcus aureus.

Authors:  Navneet Kaur; Rahul Dilawari; Amrita Kaur; Girish Sahni; Praveen Rishi
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

Review 10.  Molecular Simulations of PEGylated Biomolecules, Liposomes, and Nanoparticles for Drug Delivery Applications.

Authors:  Hwankyu Lee
Journal:  Pharmaceutics       Date:  2020-06-10       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.